Atreides Management LP Acquires 1,549,144 Shares of Astera Labs, Inc. $ALAB

Atreides Management LP lifted its position in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 2,496.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,611,194 shares of the company’s stock after acquiring an additional 1,549,144 shares during the quarter. Astera Labs makes up approximately 3.3% of Atreides Management LP’s portfolio, making the stock its 6th biggest position. Atreides Management LP’s holdings in Astera Labs were worth $268,038,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of ALAB. Royal Bank of Canada boosted its holdings in shares of Astera Labs by 167.3% during the 1st quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock valued at $9,097,000 after acquiring an additional 95,409 shares in the last quarter. AQR Capital Management LLC boosted its holdings in shares of Astera Labs by 213.4% during the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock valued at $680,000 after acquiring an additional 7,756 shares in the last quarter. Empowered Funds LLC boosted its holdings in shares of Astera Labs by 917.3% during the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock valued at $277,000 after acquiring an additional 4,183 shares in the last quarter. First Trust Advisors LP boosted its holdings in shares of Astera Labs by 102.0% during the 2nd quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock valued at $10,196,000 after acquiring an additional 56,952 shares in the last quarter. Finally, Brown Advisory Inc. boosted its holdings in shares of Astera Labs by 54.9% during the 2nd quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock valued at $505,000 after acquiring an additional 1,977 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, CEO Jitendra Mohan sold 325,693 shares of Astera Labs stock in a transaction dated Friday, April 17th. The stock was sold at an average price of $172.14, for a total transaction of $56,064,793.02. Following the completion of the transaction, the chief executive officer owned 4,079,322 shares in the company, valued at approximately $702,214,489.08. The trade was a 7.39% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of Astera Labs stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $290.30, for a total value of $116,120,000.00. Following the transaction, the chief operating officer owned 5,064,213 shares of the company’s stock, valued at $1,470,141,033.90. This trade represents a 7.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 2,161,256 shares of company stock worth $459,844,296. Insiders own 10.40% of the company’s stock.

Astera Labs Price Performance

Shares of Astera Labs stock opened at $374.68 on Thursday. Astera Labs, Inc. has a one year low of $84.78 and a one year high of $398.13. The firm has a market capitalization of $64.22 billion, a price-to-earnings ratio of 253.16, a PEG ratio of 4.79 and a beta of 3.95. The business has a 50-day simple moving average of $252.64 and a 200 day simple moving average of $183.89.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. The business had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm’s revenue was up 93.5% compared to the same quarter last year. During the same period in the previous year, the company posted $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, sell-side analysts expect that Astera Labs, Inc. will post 1.84 EPS for the current year.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera Labs introduced its Scorpio X-Series 320-Lane Smart Fabric Switch, a new connectivity product aimed at improving AI cluster efficiency and strengthening its role in rack-scale AI infrastructure. Astera Labs (ALAB) Introduces Scorpio X-Series 320-Lane Smart Fabric Switch to Optimize AI Cluster Efficiency
• Positive Sentiment: Several recent articles and commentary remain bullish on ALAB, with one Seeking Alpha piece arguing the company could become “the fabric of the AI factory” and another highlighting it as a top up-and-coming stock for the next few years. Astera Labs Could Become The Fabric Of The AI Factory
• Positive Sentiment: Jim Cramer also called ALAB “out of this world,” reinforcing investor enthusiasm around the company’s AI growth story. Jim Cramer on Astera Labs: “This Stock Is Out of This World”
• Neutral Sentiment: Analyst discussions continue to point out that while Astera Labs is growing quickly, its premium valuation and rising competition could limit upside if execution slows. ADI vs. ALAB: Which AI Semiconductor Stock is a Better Buy?
• Negative Sentiment: The stock has recently been hit by a steep decline and has drawn attention for trading under pressure, with investors likely taking profits after a strong run and reacting to its high expectations. Astera Labs stock is under pressure: What’s happening today?
• Negative Sentiment: Recent reports also noted insider selling, though the activity may have been preplanned, which can still weigh on sentiment when the stock is richly valued. Insiders Sell Top Tech Plays: Should Investors Buy, Sell, or Hold? (ALAB)

Analysts Set New Price Targets

Several research analysts recently issued reports on the company. Evercore reaffirmed an “outperform” rating and set a $297.00 target price on shares of Astera Labs in a research report on Tuesday, May 19th. Needham & Company LLC raised their target price on Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Morgan Stanley raised their target price on Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. TD Cowen raised their target price on Astera Labs from $140.00 to $225.00 and gave the stock a “hold” rating in a research report on Wednesday, May 6th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and set a $270.00 target price on shares of Astera Labs in a research report on Wednesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $233.75.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.